We are live on ! Find out more
ANTH

Anthera Pharmaceuticals, Inc.
ANTH

Delisted

ANTH was delisted on the 27th of June, 2018.

73 hedge funds and large institutions have $142M invested in Anthera Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

375% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 8

115% more capital invested

Capital invested by funds: $65.9M → $142M (+$75.7M)

82% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 11

70% more funds holding

Funds holding: 4373 (+30)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

9% less call options, than puts

Call options by funds: $1.2M | Put options by funds: $1.31M

Holders
73
Holders Change
+30
Holders Change %
+69.77%
% of All Funds
1.97%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
38
Increased
20
Reduced
11
Closed
8
Calls
$1.2M
Puts
$1.31M
Net Calls
-$113K
Net Calls Change
-$42K
Name Holding Trade Value Shares
Change
Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$715K +$480K +10,370 New
Northern Trust
27
Northern Trust
Illinois
$632K +$150K +3,239 +55%
TC
28
TFS Capital
Pennsylvania
$593K +$398K +8,597 New
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$564K +$379K +8,177 New
Goldman Sachs
30
Goldman Sachs
New York
$563K +$270K +5,839 +250%
AQR Capital Management
31
AQR Capital Management
Connecticut
$549K +$368K +7,957 New
Deutsche Bank
32
Deutsche Bank
Germany
$532K -$674K -14,567 -65%
Charles Schwab
33
Charles Schwab
California
$448K +$301K +6,492 New
TA
34
Teachers Advisors
New York
$448K +$301K +6,502 New
Millennium Management
35
Millennium Management
New York
$441K +$156K +3,369 +111%
Citadel Advisors
36
Citadel Advisors
Florida
$390K +$93.1K +2,011 +55%
CS
37
Credit Suisse
Switzerland
$341K +$229K +4,947 New
OAM
38
Oxford Asset Management
United Kingdom
$337K +$226K +4,881 New
Jacobs Levy Equity Management
39
Jacobs Levy Equity Management
New Jersey
$328K -$14.5K -313 -6%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$264K +$177K +3,834 New
MLICM
41
Metropolitan Life Insurance Company (MetLife)
New York
$234K +$157K +3,394 New
LPL Financial
42
LPL Financial
California
$221K +$151K +3,262 New
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$203K +$136K +2,941 New
NFA
44
Nationwide Fund Advisors
Ohio
$200K +$134K +2,895 New
BA
45
BlackRock Advisors
Delaware
$184K +$124K +2,674 New
AIG
46
American International Group
New York
$181K +$121K +2,624 New
VOYA Investment Management
47
VOYA Investment Management
Georgia
$169K +$114K +2,456 New
CSS
48
Cubist Systematic Strategies
Connecticut
$166K +$111K +2,404 New
SGAM
49
Smith Group Asset Management
Texas
$166K +$111K +2,405 New
EDRH
50
Edmond de Rothschild Holding
Switzerland
$129K +$86.8K +1,875 New

ANTH Hedge Fund Activity: Q2 2015 in Review

73 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Anthera Pharmaceuticals, Inc. (ANTH) for Q2 2015, worth a combined $142M — up 115% from $65.9M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new ANTH positions and 8 closed out — a net gain of 30 holders — while 20 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $5.08M. The largest seller was Broadfin Capital, cutting an estimated $6.08M.

  • 73 institutional investors held Anthera Pharmaceuticals, Inc. (ANTH) as of Q2 2015, up from 43 in Q1 2015.
  • Funds reported $142M of Anthera Pharmaceuticals, Inc. stock for Q2 2015, up 115% quarter-over-quarter.
  • 38 funds opened new Anthera Pharmaceuticals, Inc. positions in Q2 2015 and 8 closed out, a net change of +30 holders.
  • The largest Anthera Pharmaceuticals, Inc. buyer in Q2 2015 was BlackRock Fund Advisors, an estimated $5.08M added.
  • The largest Anthera Pharmaceuticals, Inc. seller in Q2 2015 was Broadfin Capital, an estimated $6.08M sold.

Based on aggregated 13F filings for Q2 2015.